CMS told pharmacists to start preparing for a late September national coverage determination (NCD) for preexposure prophylaxis (PrEP) using antiretroviral drugs to prevent HIV, and offered additional guidance on how they should do so in a “frequently asked questions” document posted Tuesday (June 25). “CMS received public feedback asking that more technical information for submitting future Medicare Part B claims for PrEP for HIV be released in advance of the final NCD. This FAQ provides more technical detail following the...